摘要
目的:探讨改良Duhamel术治疗成人先天性巨结肠(Hirschsprung’s disease,HD)及先天性巨结肠类缘病(Hirschsprung’s allied disorder,HAD)的疗效与安全性。方法:回顾性分析2012年1月至2011年1月间在重庆医科大学附属第一、第二医院Ⅰ期接受改良Duhamel术(D组,n=16)或低位直肠前切除术(L组,n=13)治疗的29例成人HD及HAD患者的临床资料。结果:无术中死亡病例。D组在术前生活质量评分[(2.2±0.7)分;(15.1±1.0)分]、手术时间(160±21)min和术后并发症发生率上与L组差异均无统计学意义(P>0.05)。但D组术中出血量(54.4±23.7)ml少于L组(t=2.394,P=0.028),术后住院时间(12.6±4.1)d短于L组(t=2.381,P=0.025),术后生活质量评分(4.4±1.4;17.9±1.2)分高于L组(t=2.090,P=0.046;t=2.224,P=0.035)。有严重并发症未解决或接受再次手术的6例病例视为手术失败,其中D组2例,L组4例。结论:改良Duhamel术治疗HD及HAD疗效确切,安全性高。
Objective:To evaluate the clinical efficacy and safety of modified Duhamel procedure for Hirschsprung's disease (HD) and Hirschsprung's allied disorder(HAD) in adults. Methods:Clinical data of 29 adult patients with HD and HAD who underwent one- stage modified Duhamel procedure(D group,n=16) or low anterior resection(L group,n=13) between January 2001 and January 2012 were analyzed respectively. Results:All operations were one-stage procedure without death case. There was no significant difference in mean preoperative life quality score((2.2±0.7) or (15.1 ± 1.0)), operation time (( 160± 21) rain) and incidences of postoperative complications between two groups (P〉0.05). However, there were less mean intraoperative blood loss ((54.4 ± 23.7) ml,t=2.394, P= 0.028) ,shorter mean postoperative hospital stay( ( 12.6 ± 4.1 ) d,t=2.381 ,P=0.025) and higher postoperative life quality score( (4.4± 1.4) ,t=2.090,P=0.046 and (17.9 ± 1.2) ,t=2.224,P=0.035) in D group compared with those of L group. Of the six patients who were considered treatment failures with unsolved serious complications or reoperations, 2 patients were from D group and 4 patients were from L group. Conclusions : Modified Duhamel procedure is safe and effective in the treatment of HD and HAD in adults.
出处
《重庆医科大学学报》
CAS
CSCD
北大核心
2014年第1期94-97,共4页
Journal of Chongqing Medical University